Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04978> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04978 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04978 label "SP1049C [drugbank:DB04978]" assertion.
- drugbank:DB04978 seeAlso DB04978 assertion.
- drugbank:DB04978 description "SP1049C is a novel anthracycline chemotherapeutic agent designed to overcome drug resistance in a number of cancers. It has successfully completed Phase 1 trials. Phase 2 results are currently under final review. Preliminary data, in its first clinically tested indication, shows that SP1049C is active in Stage IV non-resectable adenocarcinoma of the oesophagus. Median survival is encouraging and correlates strongly with dose levels." assertion.
- drugbank:DB04978 identifier "drugbank:DB04978" assertion.
- drugbank:DB04978 title "SP1049C" assertion.
- drugbank:DB04978 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04978 drugbank_vocabulary:drugbank-id "DB04978" assertion.
- drugbank:DB04978 bio2rdf_vocabulary:x-identifiers.org DB04978 assertion.
- drugbank:DB04978 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04978" assertion.
- drugbank:DB04978 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04978 bio2rdf_vocabulary:identifier "DB04978" assertion.